Gene-environment interactions in hypertension

Current Hypertension Reports

Volumn 1, Issue 1, 1999, Pages 42-50

  Pausova, Zdenka ^a   Tremblay, Johanne ^a   Hamet, Pavel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENETIC PREDISPOSITION; GENETICS; HUMAN; HYPERTENSION; LIFESTYLE; RAT; RAT STRAIN; REVIEW; RISK FACTOR; SOCIAL ENVIRONMENT;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LIFE STYLE; RATS; RATS, INBRED STRAINS; RISK FACTORS; SOCIAL ENVIRONMENT;

EID: 0033068856     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0072-z     Document Type: Article

References (89)

1. Williams RR, Hunt SC, Hasstedt SJ, et al.: Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension 1991, 18(Suppl I):I29-I37.
2. Hunt SC, Williams RR, Barlow GK: Comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 1986, 39:809-821.
3. Williams RR, Hunt SC, Hasstedt SJ, et al.: The genetics of hypertension: an unresolved puzzle with many pieces. In Human Genetics. Edited by Vogel F, Sperling K. Berlin: Springer Verlag; 1987:311-325.
4. Burke W, Motulsky AG: Hypertension. In The Genetic Basis of Human Diseases. Edited by King RA, Rotter JI, Motulsky AG. New York: Oxford University Press; 1992:170-191.
5. Kurtz TW, Spence MA: Genetics of essential hypertension. Am J Med 1993, 94:77-84.
6. Schork NJ, Nath SP, Lindpainter K, Jacob HJ: Extensions to quantitative trait locus mapping in experimental organisms. Hypertension 1996, 28:1104-1111.
7. Hamet P: Environmentally-regulated genes of hypertension. Clin Exper Hypertens 1996, 18:267-278.
8. Hamet P: Environmental stress and genes of hypertension. Clin Exp Pharmacol Physio 1995, 22(Suppl 12):394-398.
9. Hamet P, Pausova Z, Adarichev S, et al.: Hypertension: genes andenvironment. J Hypertens 1998, 16:397-418.
10. Zerba KE, Sing CF: The role of genome type-environment interaction and time in understanding the impact of genetic polymorphisms on lipid metabolism. Curr Opin Lipidol 1993, 4:152-162. (Pubitemid 23108641)
11. Garte S, Zocchetti C, Taioli E: Gene-environment interactions in the application of biomarkers of cancer susceptibility in epidemiology. Sci Publ 1997, 142:251-264.
12. Khoury MJ, Adams MJ, Flanders WD: An epidemiologic approach to ecogenetics. Am J Hum Genet 1988, 42:89-95. (Pubitemid 18081285)
13. Rapp JP, Deng H: Development and characteristics of inbred strains of Dahl salt sensitive and salt-resistant rats. Hypertension 1985, 7:340-349. (Pubitemid 15021172)
14. Yagil Y, Yagil C: Genetic basis of salt-susceptibility in the Sabra rat model of hypertension. Kidney Int 1998, 53:1493- 1500. (Pubitemid 28243733)
15. Luft FC: Bad genes, good people, association, linkage, and the environment. J Mol Med 1997, 75:309-311. (Pubitemid 27247961)
16. Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79(3):407-414. (Pubitemid 24346056)
17. Hansson JH, Nelson-Williams C, Suzuki H, et al.: Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nature Gen 1995, 11:76-82.
18. Gordon RD: Heterogeneous hypertension. Nature Gen 1995, 11:6-9.
19. Kern PA: Potential role of TNF-a and lipoprotein lipase as candidate genes for obesity J Nutr 1997, 127:1917S-1922S.
20. Eaton SB, Konner M, Shostak M: Stoneagers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 1988, 84:739-749.
21. Schork NJ, Cardon LR, Xu X: The future of genetic epidemiology. Trends Genet 1998, 14:266-272. (Pubitemid 28341787)
22. Julius S: The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension? Clin Exp Hypertens 1995, 17:375 386.
23. Henry JP, Cassel JC: Psyhcosocial factors in essential hypertension: recent epidemiologic and animal experimental evidence. Am J Epidemiol 1969, 90:171-200.
24. Widgren BR, Wikstrand J, Berglund G, Andersson OK: Increased response to physical and mental stress in men with hypertensive parents. Hypertension 1992, 20:606 611.
25. Spence JD, Bass M, Cameron Robinson H, et al.: Prospective study of ambulatory monitoring and echocardiography in borderline hypertension. Clin Invest Med 1991, 14(3):241- 250.
26. Pravenec M, Sun YL, Kunes J, et al.: Environmental susceptibility in hypertension: potential role of HSP70 and TNF-a genes. J Vasc Med Biol 1991, 3:297-302. (Pubitemid 23038862)
27. Dumas P, Pausova Z, Krenova D, et al.: QTL of the stress response by total genome scan of rat recombinant inbred strains: evidence for salt-sensitive loci [abstract]. The 9th International Symposium of SHR and Cardiovascular Genetics. Montreal, Canada, 1997.
28. Hamet P, Kaiser MA, Sun YL, et al.: HSP27 locus cosegregates with left ventricular mass independently of blood pressure. Hypertension 1996, 28:1112-1117. (Pubitemid 26415835)
29. Dumas P, Tremblay J, Hamet P: Stress modulation by electrolytes in salt-sensitive spontaneously hypertensive rats. Am J Med Sci 1994, 307(Suppl 1):130-137.
30. Dibona GF: Neural control of renal tubular solute and water transport. Miner Electrolyte Metab 1989, 15:44-50.
31. Koepke JP, Dibona GF: High sodium intake enhances renal nerve and antinatriuretic responses to stress in spontaneously hypertensive rats. Hypertension 1985, 7:357-363. (Pubitemid 15021174)
32. Staessen JA, Poulter NR, Fletcher AE, et al.: Psycho-emotional stress salt intake may interact to raise blood pressure. J Cardiovasc Risk 1994, 1:45-51.
33. Weinberger MH: Salt sensitivity: does it play an important role in the pathogenesis and treatment of hypertension. Curr Opin Nephrol Hypertens 1996, 5:205-208. (Pubitemid 26194550)
34. Tobian L: The protective effects of high-potassium diets in hypertension, and the mechanisms by which high-NaCl diets produce hypertension: a personal view. In Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. Edited by Laragh JH, Brenner BM. New York: Raven Press Ltd.; 1995:299-312.
35. Rapp JP, Wang SM, Deng H: A genetic polymorphism in the renin gene of Dahl rats segregates with blood pressure. Science 1989, 243:542 544.
36. Cowley AW Jr: Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr 1997, 65:587S- 593S.
37. Deng Y, Rapp JP: Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nature Gen 1992, 1:267-272.
38. Harris EL, Dene H, Rapp JP: Sa gene and blood pressure cosegregation using Dahl salt-sensitive rats Am J Hypertens 1993, 6:330-334.
39. Deng AY, Dene H, Pravenec M, Rapp JP: Genetic mapping of two new blood pressure quantitative trait loci in the rat by genotyping endothelin system genes J Clin Invest 1994, 93:2701-2709.
40. St-Lezin E, Pravenec M, Wong AL, et al.: Effects of renin gene transfer on blood pressure and renin gene expression in a congenic strain of Dahl salt-resistant rats. J Clin Invest 1996, 97:522-527. (Pubitemid 26039419)
41. Deng AY, Dene H, Rapp JP: Congenic strains for the blood pressure quantitative trait locus on rat chromosome 2. Hypertension 1997, 30[part 1]:199-202. (Pubitemid 27328997)
42. Hamet P, Mongeau E, Lambert J, et al.: Interactions among calcium, sodium and alcohol intake as determinants of blood pressure. Hypertension 1991, 17(Suppl I):I150-I154
43. Hamet P, Daignault-Gelinas M, Lambert J, et al.: Epidemiological evidence of an interaction between calcium and sodium intake impacting on blood pressure: a Montreal study. Am J Hypertens 199, 5:378-385.
44. Spiegelman D, Israel RG, Bouchard C, Willett WC: Absolute fat mass, percent body fat, and body-fat distribution which is the real determinant of blood pressure and serum glucose. Am J Clin Nutr 1992, 55:1033-1044.
45. Joffres MR, Hamet P, Rabkin SW, et al.: Prevalence, control and awareness of high blood pressure among Canadian adults. Can Med Assoc J 1992, 146:1997-2005.
46. Zhang Y, Proenca R, Maffel M, et al.: Positional cloning of the mouse obese gene and its human homologue Nature 1994, 372:425-431.
47. Tartagli LA, Dembrski M, Weng X, et al.: Identification and expression cloning of a leptin receptor, OBR. Cell 1995, 83:1263-1271. (Pubitemid 26007816)
48. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87:377-389. (Pubitemid 26374313)
49. Tritos NA, Mantzoros CS: Leptin: its role in obesity and beyond. Diabetologia 1997, 40:1371-1379. (Pubitemid 28004929)
50. Considine R, Sinha M, Heiman M, et al.: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 1995, 334:292-295. (Pubitemid 26033933)
51. Maffei M, Halaas J, Ravussin E, et al.: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995, 1:1155- 1161.
52. Frederich RC, Hamann A, Anderson S, et al.: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med 1995, 12:1311-1314.
53. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409-414.
54. Haynes WG, Sivitz WI, Morgan DA, et al.: Sympathetic and cardiorenal actions of leptin. Hypertension 1997, 30:619 623.
55. Barker DJP, Osmond C, Golding J, et al.: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989, 298:564-567. (Pubitemid 19072097)
56. Chertow GM, Brenner BM: Low birth weight as a risk factor for juvenile and adult hypertension. In Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:89-96.
57. Cater J, Gill M: The follow-up study: medical aspects. In Low birthweight: A Medical, Psychological and Social Study. Edited by Illsley R, Mitchell RG. Chichester: John Wiley; 1984:191-205.
58. Barker DJ, Gluckman PD, Godfrey KM, et al.: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938-941. (Pubitemid 23109122)
59. Godfrey K, Robinson S, Barker DJP, et al.: Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. BMJ 1996, 312:410-414. (Pubitemid 26055356)
60. Campbell DM, Hall MH, Barker DJP, et al.: Diet in pregnancy and the offspring's blood pressure 40 years later. Br J Obstet Gynecol 1996, 103:273-280. (Pubitemid 26072736)
61. Langle SC, Jackson AA: Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci (Colch) 1994, 86:217-22 . (Pubitemid 24056702)
62. .Delafontaine P, Bernstein KE, Alexander RW: Insulin-like growth factor I gene expression in vascular cells. Hypertension 1991, 17:693-699.
63. Martyn CN, Barker DJP, Jespersen S, et al.: Growth in utero, adult blood pressure, and arterial compliance. Br Heart J 1995, 73:116-121.
64. Lithell HO, McKeigue PM, Berglund L, et al.: Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 199, 312:406-410.
65. Katz EB, Stenbit AE, Hatton K, et al.: Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995, 377:151-155.
66. Stenbit A, Tsao T-S, Li J, et al.: GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nature Med 1997, 3:1096-1101. (Pubitemid 27444450)
67. Hattersley AT, Beards F, Ballantyne E, et al.: Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Gen 1998, 19:268-270. (Pubitemid 28309340)
68. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994, 23:171-175. (Pubitemid 24075306)
69. Bianchi G, Tripodi G, Casari G, et al.: Two point mutations within adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A 1994, 91:3999-4003. (Pubitemid 24139560)
70. Hamet P, Pausova Z, Dumas P, et al.: Newborn and adult recombinant inbred strains: a tool for the search of genetic determinants of target organ damage in hypertension. Kidney Int 1998, 53:1488-1492. (Pubitemid 28243732)
71. Cierpial MA, McCarty R: Hypertension in SHR rats: contribution of maternal environment. Am J Physiol 1987, 253:H980- H984.
72. Harrap SB, Nicolaci JA, Doyle AE: Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol 1986, 13:753-765. (Pubitemid 17031504)
73. Harrap SB, Van Der Merwe WM, Griffin SA, et al.: Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure longterm. Hypertension 1990, 16:603-614.
74. Wu JN, Berecek KH: Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 1993, 22:139-146. (Pubitemid 23234058)
75. Ferrari P: Pharmacogenomics: a new approach to individual therapy of hypertension? Curr Opin Nephrol Hypertens 1998, 7:217-222.
76. Grim CE, Henry JP, Myers H: High blood pressure in blacks, salt, slavery, survival, stress, and racism. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:171-207.
77. Saunders E, Weir MR, Kong BW, et al.: A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks Arch Intern Med 1990, 150:1707-1713.
78. Matterson BJ, Reda DJ, Cushman WC, et al.: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993, 328:914-921. (Pubitemid 23086643)
79. Zannad F: Concomitant diseases in elderly hypertensives: the position of nicardipine. J Hypertens 1996, 14:S37-S40 (Pubitemid 27049512)
80. Schild L, Schneeberger E, Gautschi I, Firsov D: Identification of amino acid residues in the alpha, beta, and gamma subunits of the epithelial sodium channel (ENaC) involved in amiloride block and ion permeation. J Gen Physiol 1997, 109:15-26. (Pubitemid 27030190)
81. Lifton RP, Dluhy RG, Powers M, et al.: Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nature Gen 1992, 2:66-74.
82. Vincent M, Samani NJ, Gauguier D, et al.: A pharmacogenetic approach to blood pressure in Lyon hypertensive rats: a chromosome 2 locus influences the response to a calcium antagonist. J Clin Invest 1997, 100:2000-2006. (Pubitemid 27459353)
83. Deng AY, Dene H, Rapp JP: Mapping of a quantitative trait locus for blood pressure on rat chromosome 2. J Clin Invest 1994, 94:431-436. (Pubitemid 24218122)
84. Samani NJ, Gauguier D, Vincent M, et al.: Analysis of quantitative trait loci for blood pressure on rat chromosome 2 and 13. Hypertension 1996, 28:1118-1122. (Pubitemid 26415836)
85. Casari G, Barlassina C, Cusi D, et al.: Association of the alphaadducin locus with essential hypertension. Hypertension 1995, 25:320-326.
86. Cusi D, Barlassina C, Azzani T, et al.: Polymorphisms of a- adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349:1353-1357. (Pubitemid 27197537)
87. Tamaki S, Iwai N, Tsujita Y, et al.: Polymorphism of alphaadducin in Japanese patients with essential hypertension. Hypertens Res 1998, 21:29-32.
88. Dudley C, Keavney B, Casadei B, et al.: Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens 199, 14:259-262.
89. Penno G, Chaturvedi N, Talmud PJ, et al.: Effect of angiotensin- converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients. Diabetes 1998, 47:1507-1511. (Pubitemid 28396957)